Maaike Kreft
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Cholesterol biosynthesis as a drug-induced vulnerability in diffuse large B cell lymphoma insensitive to EZH2 inhibition.
Journal: Neoplasia (New York, N.Y.)
Published: July 16, 2025
Colorectal carcinoma progression is not influenced by the pseudokinase PEAK1.
Journal: Scientific reports
Published: April 08, 2024
Caskin2 is a novel talin- and Abi1-binding protein that promotes cell motility.
Journal: Journal of cell science
Published: March 15, 2024
Molecular dependencies and genomic consequences of a global DNA damage tolerance defect.
Journal: Genome biology
Published: February 22, 2024
Gemcitabine as chemotherapy of head and neck cancer in Fanconi anemia patients.
Journal: Oncogenesis
Published: August 10, 2023
A C57BL/6J Fancg-KO Mouse Model Generated by CRISPR/Cas9 Partially Captures the Human Phenotype.
Journal: International journal of molecular sciences
Published: June 14, 2023
Huwe1 supports B-cell development, B-cell-dependent immunity, somatic hypermutation and class switch recombination by regulating proliferation.
Journal: Frontiers in immunology
Published: July 05, 2022
Division of labor within the DNA damage tolerance system reveals non-epistatic and clinically actionable targets for precision cancer medicine.
Journal: Nucleic acids research
Published: April 12, 2022
PEAK1 Y635 phosphorylation regulates cell migration through association with Tensin3 and integrins.
Journal: The Journal of cell biology
Published: August 05, 2021
Last Updated: 09/26/2026